## BACKGROUND. The clinical value of prostate-specific antigen (PSA) density in differentiating between prostate cancer and benign prostatic hyperplasia has been the subject of several studies. In this context the question has been raised about the diagnostic benefit of PSA transition-zone density
โฆ LIBER โฆ
Reply to Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels
โ Scribed by Benson, Mitchell C.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 59 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Improvement of specificity in PSA-based
โ
Horninger, W.; Reissigl, A.; Klocker, H.; Rogatsch, H.; Fink, K.; Strasser, H.;
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 135 KB
๐ 1 views
Improvement of prostate cancer screening
โ
Reissigl, A.; Klocker, H.; Pointner, J.; Ennemoser, O.; Falk, M.; Bartsch, G.
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 252 KB
๐ 2 views
## Background: The measurement of prostate specific antigen (psa) is widely used in screening programs for early detection of prostate cancer. however the specificity for cancer detection is limited because serum psa is also elevated in patients with benign prostatic-hyperplasia (bph) and/or prosta